Atlas FDA

ExAblate Neuro Thalamotomy

FDA premarket approval P150038/S004 · decided 2017-10-13

Approval details

PMA number
P150038
Supplement
S004
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
ExAblate Neuro Thalamotomy
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2017-08-16
Decision date
2017-10-13
Days to decision
58 days
Decision code
APPR
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.